Cargando…

The course of action for effective anti-cytokine treatment in COVID-19

Detalles Bibliográficos
Autores principales:	Cavalli, Giulio, Dagna, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555968/ https://www.ncbi.nlm.nih.gov/pubmed/34756179 http://dx.doi.org/10.1016/S2213-2600(21)00405-7

Ejemplares similares

The right place for IL-1 inhibition in COVID-19
por: Cavalli, Giulio, et al.
Publicado: (2021)

Cutaneous vasculitis following COVID-19 vaccination
por: Cavalli, Giulio, et al.
Publicado: (2021)

The conundrum of interleukin-6 blockade in COVID-19
por: Campochiaro, Corrado, et al.
Publicado: (2020)

GM-CSF in the treatment of COVID-19: a new conductor in the pathogenesis of cytokine storm?
por: Favalli, Ennio Giulio, et al.
Publicado: (2020)

Granulocyte-macrophage colony stimulating factor in COVID-19: friend or foe?
por: Mehta, Puja, et al.
Publicado: (2021)

IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19
por: Della-Torre, Emanuel, et al.
Publicado: (2021)

Effect of anakinra in COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Large-scale use of hydroxychloroquine for COVID-19 confirms safety, if not effectiveness
por: Cavalli, Giulio, et al.
Publicado: (2020)

Can Cytokine Blocking Prevent Depression in COVID-19 Survivors?
por: Benedetti, Francesco, et al.
Publicado: (2020)

COVID-19 cytokine storm: targeting the appropriate cytokine
por: Cron, Randy Q
Publicado: (2021)

Correction to: Can Cytokine Blocking Prevent Depression in COVID-19 Survivors?
por: Benedetti, Francesco, et al.
Publicado: (2021)

COVID-19 care in India: the course to self-reliance
por: Balsari, Satchit, et al.
Publicado: (2020)

Clinical course and mortality risk of severe COVID-19
por: Weiss, Paul, et al.
Publicado: (2020)

Can tocilizumab calm the cytokine storm of COVID-19?
por: Schulert, Grant S
Publicado: (2020)

No perfect therapy for the imperfect COVID-19 cytokine storm
por: Cron, Randy Q
Publicado: (2022)

COVID-19: combining antiviral and anti-inflammatory treatments
por: Stebbing, Justin, et al.
Publicado: (2020)

COVID-19 interstitial pneumonia: monitoring the clinical course in survivors
por: Raghu, Ganesh, et al.
Publicado: (2020)

Anticoagulation in COVID-19: reaction to the ACTION trial
por: Berger, Jeffrey S, et al.
Publicado: (2021)

COVID-19 cytokine storm syndrome: a threshold concept
por: Chen, Luke Y C, et al.
Publicado: (2021)

Cytokine adsorption during ECMO for COVID-19-related ARDS
por: Shekar, Kiran, et al.
Publicado: (2021)

COVID-19: risk for cytokine targeting in chronic inflammatory diseases?
por: Schett, Georg, et al.
Publicado: (2020)

Inflammatory cytokines and cardiac arrhythmias: the lesson from COVID-19
por: Lazzerini, Pietro Enea, et al.
Publicado: (2022)

Is IL-6 a key cytokine target for therapy in COVID-19?
por: Jones, Simon A., et al.
Publicado: (2021)

India's resurgence of COVID-19: urgent actions needed
por: Aiyar, Yamini, et al.
Publicado: (2021)

Anakinra for patients with COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

How will country-based mitigation measures influence the course of the COVID-19 epidemic?
por: Anderson, Roy M, et al.
Publicado: (2020)

India's COVID-19 crisis: a call for international action
por: Kuppalli, Krutika, et al.
Publicado: (2021)

The necessity for intra-action reviews during the COVID-19 pandemic
por: Mayigane, Landry Ndriko, et al.
Publicado: (2020)

COVID-19 and mass incarceration: a call for urgent action
por: Macmadu, Alexandria, et al.
Publicado: (2020)

COVID-19 vaccine hesitancy in Africa: a call to action
por: Mutombo, Polydor Ngoy, et al.
Publicado: (2022)

COVID-19 and the anti-lessons of history
por: Peckham, Robert
Publicado: (2020)

EU guidance impedes humanitarian action to prevent COVID-19 in Syria
por: Hussain, Hamid Yahiya, et al.
Publicado: (2020)

COVID-19 impact on early career investigators: a call for action
por: Levine, Ross L., et al.
Publicado: (2020)

A call for action for COVID-19 surveillance and research during pregnancy
por: Buekens, Pierre, et al.
Publicado: (2020)

Racial and ethnic differences in COVID-19 outcomes: a call to action
por: Robinson, Philip C, et al.
Publicado: (2022)

Charting a course for the management of long COVID
por: Beasley, Richard, et al.
Publicado: (2021)

A life-course model for healthier ageing: lessons learned during the COVID-19 pandemic
por: Jowell, Ashley, et al.
Publicado: (2020)

Novel paediatric presentation of COVID-19 with ARDS and cytokine storm syndrome without respiratory symptoms
por: Pain, Clare E, et al.
Publicado: (2020)

Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2021)

α1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action
por: Yang, Chengliang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9j3vhmhj3p92rmf99rfclj8t72